Johnson & Johnson Unit Minimized Risks Of Drug
Janssen Pharmaceutica Products, a unit of Johnson & Johnson, notified doctors that it minimized the risks of a popular drug for schizophrenia in promotional materials, according to the Associated Press. Janssen sent a two-page letter to health care workers this week to clarify the risks of the drug, the report said, citing Janssen spokeswoman Carol Goodrich.